
Commercial UAV – Commercial UAV News today announced it will host a free webinar titled “UAS Beyond Imagery: Exploring the Evolving Capabilities of Spray Drone Technology“ on Tuesday, September 16, 2025, at 1:00 PM EST. The program will feature Kelley Wittenberg of Central UAS Technologies, who will share data-driven insights and real-world case studies that illustrate the growing value of spray drone technology across agriculture, forestry, and public health.
Spray drones are experiencing rapid adoption as UAVs move from gathering imagery to delivering direct action in the field. With payload capacities and precision systems advancing quickly, operators are achieving new efficiencies and addressing applications once considered impossible.
“Spray drones are one of the fastest-growing applications in the UAV market,” said Matt Collins, Content Manager for Commercial UAV News. “They mark a shift from drones being tools for collecting data to becoming tools that solve problems. At Commercial UAV News, we’re focused on highlighting the people and technologies driving that shift. This webinar with Central UAS Technologies is a chance to hear directly from a team that has been innovating in this space for nearly a decade.”
Wittenberg will highlight several case studies that demonstrate how spray drones are tackling unique challenges in the field. These include autonomous mosquito larvicide applications guided by LiDAR topography maps, treating invasive Jubata grass on California’s inaccessible coastal cliffs, and deploying a custom-engineered vertical spray boom for canopy penetration in Georgia pecan orchards.
“UAS technology is advancing quickly, and we’re seeing real-world results that demonstrate how impactful these systems can be across agriculture, forestry, and public health by delivering greater efficiency, better outcomes, and stronger ROI,” said Kelley Wittenberg, Technical Sales, Central UAS Technologies. “Our latest case studies highlight the growing capability of drones to take on challenges that once seemed out of reach.”














